ASO作者反思：一次有益，两次是否同样有益？对复发性CRS-HIPEC治疗结直肠癌腹膜转移的批判性评估 - Suppr

Suppr

超能文献

ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.

作者信息

Laks S, Adileh M, Ben-Yaacov A, Nissan A

机构信息

Department of General and Oncological Surgery - Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel.

出版信息

Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.

DOI:10.1245/s10434-021-09704-6

PMID:33604829

Abstract

摘要

相似文献

ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.

Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.

ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer.

Ann Surg Oncol. 2021 Dec;28(13):9148-9149. doi: 10.1245/s10434-021-10369-4. Epub 2021 Jun 27.

ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.

ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis.

Ann Surg Oncol. 2020 Dec;27(13):4892-4893. doi: 10.1245/s10434-020-08491-w. Epub 2020 Apr 21.

Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.

World J Surg Oncol. 2021 May 17;19(1):151. doi: 10.1186/s12957-021-02255-w.

ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.

Ann Surg Oncol. 2023 Jul;30(7):4471-4472. doi: 10.1245/s10434-023-13522-3. Epub 2023 Apr 27.

ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.

Ann Surg Oncol. 2022 May;29(5):3347-3348. doi: 10.1245/s10434-022-11377-8. Epub 2022 Feb 25.

ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.

Ann Surg Oncol. 2023 May;30(5):2664-2665. doi: 10.1245/s10434-023-13254-4. Epub 2023 Feb 17.

ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.

Ann Surg Oncol. 2024 Mar;31(3):2008-2009. doi: 10.1245/s10434-023-14468-2. Epub 2023 Oct 18.

[Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].

Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):256-263. doi: 10.3760/cma.j.cn.441530-20201111-00604.

本文引用的文献

Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.

Ann Surg Oncol. 2021 Jun;28(6):3320-3329. doi: 10.1245/s10434-020-09165-3. Epub 2020 Sep 23.

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Am J Surg. 2020 Mar;219(3):478-483. doi: 10.1016/j.amjsurg.2019.09.017. Epub 2019 Sep 19.

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

Lancet Oncol. 2016 Dec;17(12):1709-1719. doi: 10.1016/S1470-2045(16)30500-9. Epub 2016 Oct 12.

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Ann Surg. 2006 Feb;243(2):212-22. doi: 10.1097/01.sla.0000197702.46394.16.

Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy.

Cancer Treat Res. 1996;82:317-25. doi: 10.1007/978-1-4613-1247-5_20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.

作者信息

Laks S, Adileh M, Ben-Yaacov A, Nissan A

机构信息

Department of General and Oncological Surgery - Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel.

出版信息

Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.

DOI:10.1245/s10434-021-09704-6

PMID:33604829

Abstract

摘要